Series A - New Haven Pharmaceuticals - Oct 29, 2012 Funding Round Profile - Cointime

Bitcoin $86,446.95 -2.56%
Ethereum $3,130.38 -5.96%
BNB $605.57 -6.05%
Optimism $1.52 -15.04%
Arbitrum $0.58 -13.23%
Solana $204.74 -6.25%
Polygon $0.37 -12.44%
Cosmos $4.92 -11.13%
Avalanche $31.64 -13.83%

Bitcoin $86,446.95 -2.56%
Ethereum $3,130.38 -5.96%
BNB $605.57 -6.05%
Optimism $1.52 -15.04%
Arbitrum $0.58 -13.23%
Solana $204.74 -6.25%
Polygon $0.37 -12.44%
Cosmos $4.92 -11.13%
Avalanche $31.64 -13.83%

New Haven Pharmaceuticals

company

Funding Round

Series A

Money Raised

$ 6.49M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
Advantage Capital	-	-	-	Detail
EJ Funds	-	-	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Sep 30, 2012	Series Unknown	0	Advantage Capital	Detail